...
首页> 外文期刊>Malaria Journal >Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy
【24h】

Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy

机译:改变抗疟药物治疗政策后,加纳恶性疟原虫分离株的pfmdr1基因拷贝数增加,pfcrt和pfmdr1耐药等位基因下降

获取原文
           

摘要

Background With the introduction of artemisinin-based combination therapy (ACT) in 2005, monitoring of anti-malarial drug efficacy, which includes the use of molecular tools to detect known genetic markers of parasite resistance, is important for first-hand information on the changes in parasite susceptibility to drugs in Ghana. This study investigated the Plasmodium falciparum multidrug resistance gene (pfmdr1) copy number, mutations and the chloroquine resistance transporter gene (pfcrt) mutations in Ghanaian isolates collected in seven years to detect the trends in prevalence of mutations. Methods Archived filter paper blood blots collected from children aged below five years with uncomplicated malaria in 2003–2010 at sentinel sites were used. Using quantitative real-time polymerase chain reaction (qRT-PCR), 756 samples were assessed for pfmdr1 gene copy number. PCR and restriction fragment length polymorphism (RFLP) were used to detect alleles of pfmdr1 86 in 1,102 samples, pfmdr1 184, 1034, 1042 and 1246 in 832 samples and pfcrt 76 in 1,063 samples. Merozoite surface protein 2 (msp2) genotyping was done to select monoclonal infections for copy number analysis. Results The percentage of isolates with increased pfmdr1 copy number were 4, 27, 9, and 18% for 2003–04, 2005–06, 2007–08 and 2010, respectively. Significant increasing trends for prevalence of pfmdr1 N86 (×2?=?96.31, p <0.001) and pfcrt K76 (×2 = 64.50, p <0.001) and decreasing trends in pfmdr1 Y86 (×2?=?38.52, p <0.001) and pfcrt T76 (×2?=?43.49, p <0.001) were observed from 2003–2010. The pfmdr1 F184 and Y184 prevalence showed an increasing and decreasing trends respectively but were not significant (×2?=?7.39,p=0.060; ×2?=?7.49, p?=?0.057 respectively). The pfmdr1 N86-F184-D1246 haplotype, which is alleged to be selected by artemether-lumefantrine showed a significant increasing trend (×2?=?20.75, p
机译:背景技术随着2005年基于青蒿素的联合疗法(ACT)的引入,监测抗疟疾药物的功效(包括使用分子工具检测已知的寄生虫抗药性遗传标记)对于第一手了解有关变化的信息非常重要加纳对药物的寄生虫敏感性。这项研究调查了加纳分离物中的恶性疟原虫多药抗性基因(pfmdr1)的拷贝数,突变和氯喹抗性转运蛋白基因(pfcrt)突变,以检测突变的流行趋势。方法使用2003-2010年在前哨站点从5岁以下未合并疟疾的儿童中收集的滤纸血液印迹。使用定量实时聚合酶链反应(qRT-PCR),评估了756个样品的pfmdr1基因拷贝数。 PCR和限制性片段长度多态性(RFLP)用于检测1,102个样品中的pfmdr1 86、832个样品中的pfmdr1 184、1034、1042和1246和1,063个样品中的pfcrt 76等位基因。进行了裂殖子表面蛋白2(msp2)基因分型,以选择单克隆感染进行拷贝数分析。结果2003–04年,2005-06年,2007-08年和2010年,pfmdr1拷贝数增加的分离株百分比分别为4%,27%,9%和18%。 pfmdr1 N86(×2?=?96.31,p <0.001)和pfcrt K76(×2 = 64.50,p <0.001)的流行趋势显着增加,而pfmdr1 Y86(×2?=?38.52,p <0.001)的减少趋势显着)和pfcrt T76(×2?=?43.49,p <0.001)从2003–2010年观察到。 pfmdr1 F184和Y184的患病率分别呈上升和下降趋势,但不显着(×2θ=?7.39,p = 0.060;×2θ=?7.49,p?=?0.057)。据称由蒿甲醚-荧光黄素选择的pfmdr1 N86-F184-D1246单倍型显示出明显的增加趋势(×2≤20.75,p <0.001)。结论在分析的菌株中发现了pfmdr1基因拷贝数的增加,尽管尚无耐药性报道,但这一发现对该国ACT的使用有影响。改变治疗政策后,氯喹耐药标记物的流行趋势呈下降趋势,这表明将来有可能引入氯喹来预防加纳的儿童和孕妇等疟疾高危人群。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号